TEL-AVIV, Israel--(BUSINESS WIRE)--Israel-based Se-cure Pharmaceuticals Ltd. announced today its U.S. launch of Femarelle®, a premium supplement line for women over 40. The Femarelle® line includes three products, each one formulated for a different stage of estrogen decline, before, during and after menopause.
Femarelle® is developed from a proprietary extract, DT56a, which has been shown in clinical studies to support healthy management of menopause symptoms. Because the symptoms of estrogen decline vary from ages 40-70+, each product provides a targeted solution with additional ingredients to address the needs of the individual.
- Rejuvenate: For women in their 40s experiencing the early stages of estrogen decline, Rejuvenate promotes healthy mood, skin elasticity and restful sleep.
- Recharge: For women in their 50s, Recharge helps manage common menopause symptoms, such as hot flashes, night sweats and sleep loss.
- Unstoppable: For women in their 60s, Unstoppable promotes bone, joint and vaginal health following menopause.
“Femarelle® is a natural option to relieve the symptoms of menopause,” said Dr. Margaret Nachtigall, a founding member of the North American Menopause Society and a noted reproductive endocrinologist. “The inevitable decline in estrogen levels is experienced differently by women at different stages of life, so having three unique products ensures specific symptoms get targeted attention at the right time.”
Backed by 19 published studies in the most prestigious scientific journals, Femarelle® offers compelling, consistent and validated results for women 40 and beyond. Femarelle contains no soy isoflavones, plus each formula is tissue-specific in its mode of action for maximum focused effort and results.
Femarelle® products are guaranteed to be drug and estrogen free, as well as Non-GMO certified, Kosher, Halal and gluten free. Femarelle® can be purchased online, and in local California and Florida health food stores. Learn more at www.femarelle.us.
About Se-cure Pharmaceuticals
Founded in 1997, Se-cure Pharmaceuticals Ltd. is a clinical stage technology-driven pharmaceutical company focused on developing safe and effective therapeutic solutions, derived from botanical sources. Implementing proprietary botanical drug development and scaling technologies, Se-cure is able to introduce novel biochemical agents characterized by functionally selective mechanisms of action in the target tissues.